与饮食相关的恶心和吐的方法
David J Cangemi1, R Christopher Chase2, Brian E Lacy1
1Division of Gastroenterology & Hepatology.
Gastroenterology & hepatology
|February 3, 2025
概括
与饮食相关的恶心和吐有复杂的原因,经常因饮食而恶化. 准确的诊断,包括对胃的胃空化研究,指导针对这些常见胃肠道症状的向治疗.
科学领域:
- 胃肠病学 胃肠病学
- 消化系统疾病 消化系统疾病
- 临床医学 临床医学
背景情况:
- 恶心和吐是普遍存在的症状,需要进行医学评估.
- 食物诱导的恶心和吐表明了潜在的胃肠道病理.
- 潜在的原因是多种多样的,从胃至功能性消化不良.
研究的目的:
- 概述一种诊断与饮食相关的恶心和吐的方法.
- 审查诊断测试和识别潜在原因的标准.
- 讨论特定的胃肠道疾病及其治疗方法.
主要方法:
- 对诊断测试的审查,包括胃空化研究.
- 适用于功能性胃肠道疾病的罗马标准.
- 对常见病因学的流行病学数据的分析.
- 检查病理生理学的疾病,如胃和功能性消化不良.
主要成果:
- 胃空化研究对于诊断胃衰竭和区分其与功能性消化不良至关重要.
- 一种系统的诊断方法有助于确定与饮食相关的恶心和吐的原因.
- 各种胃肠道疾病,包括胃,功能性消化不良等,与这些症状有关.
结论:
- 准确诊断潜在原因对于有效治疗与饮食相关的恶心和吐至关重要.
- 胃排空研究在诊断工作中发挥着关键作用.
- 治疗策略必须根据确定的特定病因量身定制.
相关概念视频
Pathophysiology of Vomiting
287
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
287
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
173
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
173
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
215
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
215
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Equilibrium and Balance
4.4K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
4.4K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
200
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
200


